Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-01-01
|
Series: | Journal of Ophthalmic Inflammation and Infection |
Online Access: | https://doi.org/10.1186/s12348-024-00450-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841544362723377152 |
---|---|
author | Uwe Pleyer Carlos Pavesio Elisabetta Miserocchi Carsten Heinz Helen Devonport Víctor Llorenç Tomás Burke Vanda Nogueira Laurent Kodjikian Bahram Bodaghi |
author_facet | Uwe Pleyer Carlos Pavesio Elisabetta Miserocchi Carsten Heinz Helen Devonport Víctor Llorenç Tomás Burke Vanda Nogueira Laurent Kodjikian Bahram Bodaghi |
author_sort | Uwe Pleyer |
collection | DOAJ |
format | Article |
id | doaj-art-6c4bbb731b854467944b81c0d8cf907d |
institution | Kabale University |
issn | 1869-5760 |
language | English |
publishDate | 2025-01-01 |
publisher | SpringerOpen |
record_format | Article |
series | Journal of Ophthalmic Inflammation and Infection |
spelling | doaj-art-6c4bbb731b854467944b81c0d8cf907d2025-01-12T12:35:21ZengSpringerOpenJournal of Ophthalmic Inflammation and Infection1869-57602025-01-011511110.1186/s12348-024-00450-wCorrection: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendationsUwe Pleyer0Carlos Pavesio1Elisabetta Miserocchi2Carsten Heinz3Helen Devonport4Víctor Llorenç5Tomás Burke6Vanda Nogueira7Laurent Kodjikian8Bahram Bodaghi9Charité – Universitätsmedizin BerlinDepartment of Ophthalmology at Moorfields Eye HospitalDepartment of Ophthalmology, Ocular Immunology and Uveitis Service, University Vita-Salute, IRCCS San Raffaele Scientific InstituteDepartment of Ophthalmology at St, Franziskus Hospital MuensterBradford Teaching Hospitals NHS Foundation TrustClínic Hospital of BarcelonaDepartment of Ophthalmology, Mater Misericordiae University HospitalInstituto de Oftalmologia Dr. Gama PintoService d’Ophtalmologie, Hôpital Universitaire de La Croix-Rousse, Hospices Civils de LyonDepartment of Ophthalmology, Pitié-Salpêtrière Hospitalhttps://doi.org/10.1186/s12348-024-00450-w |
spellingShingle | Uwe Pleyer Carlos Pavesio Elisabetta Miserocchi Carsten Heinz Helen Devonport Víctor Llorenç Tomás Burke Vanda Nogueira Laurent Kodjikian Bahram Bodaghi Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations Journal of Ophthalmic Inflammation and Infection |
title | Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations |
title_full | Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations |
title_fullStr | Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations |
title_full_unstemmed | Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations |
title_short | Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations |
title_sort | correction fluocinolone acetonide 0 2 µg day intravitreal implant in non infectious uveitis affecting the posterior segment eu expert user panel consensus based clinical recommendations |
url | https://doi.org/10.1186/s12348-024-00450-w |
work_keys_str_mv | AT uwepleyer correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT carlospavesio correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT elisabettamiserocchi correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT carstenheinz correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT helendevonport correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT victorllorenc correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT tomasburke correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT vandanogueira correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT laurentkodjikian correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations AT bahrambodaghi correctionfluocinoloneacetonide02μgdayintravitrealimplantinnoninfectiousuveitisaffectingtheposteriorsegmenteuexpertuserpanelconsensusbasedclinicalrecommendations |